| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.075 | 0.6 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |